119 related articles for article (PubMed ID: 28215760)
1. Two novel cases of compound heterozygous mutations in mitofusin2: Finding out the inheritance.
Geroldi A; Lastella P; Patruno M; Gotta F; Resta N; Devigili G; Sabbà C; Gulli R; Lamp M; Origone P; Mandich P; Bellone E
Neuromuscul Disord; 2017 Apr; 27(4):377-381. PubMed ID: 28215760
[TBL] [Abstract][Full Text] [Related]
2. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype.
Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A
Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379
[TBL] [Abstract][Full Text] [Related]
3. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
[TBL] [Abstract][Full Text] [Related]
4. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review.
Tan CA; Rabideau M; Blevins A; Westbrook MJ; Ekstein T; Nykamp K; Deucher A; Harper A; Demmer L
Am J Med Genet A; 2016 Jun; 170(6):1580-4. PubMed ID: 26955893
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
[TBL] [Abstract][Full Text] [Related]
6. Novel MFN2 Missense Mutation Induces Hereditary Axonal Motor and Sensory Neuropathy in a Saudi Arabian Family.
Al-Harbi TM; Abdulmana SO; Bashir S; Dridi W
J Clin Neuromuscul Dis; 2019 Sep; 21(1):25-29. PubMed ID: 31453851
[TBL] [Abstract][Full Text] [Related]
7. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
[TBL] [Abstract][Full Text] [Related]
8. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
[TBL] [Abstract][Full Text] [Related]
9. Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.
Polke JM; Laurá M; Pareyson D; Taroni F; Milani M; Bergamin G; Gibbons VS; Houlden H; Chamley SC; Blake J; Devile C; Sandford R; Sweeney MG; Davis MB; Reilly MM
Neurology; 2011 Jul; 77(2):168-73. PubMed ID: 21715711
[TBL] [Abstract][Full Text] [Related]
10. Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.
Hikiami R; Yamashita H; Koita N; Jingami N; Sawamoto N; Furukawa K; Kawai H; Terashima T; Oka N; Hashiguchi A; Takashima H; Urushitani M; Takahashi R
J Hum Genet; 2018 Jan; 63(1):89-92. PubMed ID: 29215088
[TBL] [Abstract][Full Text] [Related]
11. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
[TBL] [Abstract][Full Text] [Related]
13. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
14. A mutation in the heptad repeat 2 domain of MFN2 in a large CMT2A family.
Dankwa L; Richardson J; Motley WW; Züchner S; Scherer SS
J Peripher Nerv Syst; 2018 Mar; 23(1):36-39. PubMed ID: 29341354
[TBL] [Abstract][Full Text] [Related]
15. Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation.
Di Meglio C; Bonello-Palot N; Boulay C; Milh M; Ovaert C; Levy N; Chabrol B
Brain Dev; 2016 May; 38(5):498-506. PubMed ID: 26686600
[TBL] [Abstract][Full Text] [Related]
16. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family.
Dankwa L; Richardson J; Motley WW; Scavina M; Courel S; Bardakjian T; Züchner S; Scherer SS
Neuromuscul Disord; 2019 Feb; 29(2):134-137. PubMed ID: 30642740
[TBL] [Abstract][Full Text] [Related]
17. Late-onset hereditary sensory and autonomic neuropathy expands the phenotypic spectrum of MFN2-related diseases.
Wu R; Fu J; Meng L; Lv H; Wang Z; Yuan Y
Neuropathology; 2018 Oct; 38(5):463-467. PubMed ID: 30011089
[TBL] [Abstract][Full Text] [Related]
18. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
Sołtysińska E; Kabzińska D; Kochański A
Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
[TBL] [Abstract][Full Text] [Related]
19. Novel mitofusin 2 splice-site mutation causes Charcot-Marie-Tooth disease type 2 with prominent sensory dysfunction.
Martikainen MH; Kytövuori L; Majamaa K
Neuromuscul Disord; 2014 Apr; 24(4):360-4. PubMed ID: 24530046
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]